Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.

04.06.2023, 2139 Zeichen

Valneva: Valneva. an Austrian/French specialty vaccine company, today announces the filing of a regulatory application with Health Canada for marketing approval of the Company’s single-shot chikungunya vaccine candidate, VLA1553, in persons aged 18 years and above. This is the second regulatory application for VLA1553 filed by Valneva, and the Company intends to make additional regulatory submissions in 2023.
Valneva: weekly performance: -3.30%

Warimpex: The business operations of the Warimpex Group expanded noticeably in the first quarter of 2023 with revenue growth of 52%. Particularly the performance of the hotels improved following a weaker prior-year period due to the pandemic, and revenues in the office segment also increased significantly thanks to the higher occupancy rates in Poland and newly let spaces in St. Petersburg. At the same time, negative property valuation results that were recognised in the first quarter of 2022 no longer applied. This resulted in a profit for the period of EUR 1.4 million for the Warimpex Group, up from minus EUR 4.4 million in the prior-year period. "We are very pleased with the good development of our business operations. While the first quarter of 2022 was still in part impacted by restrictions due to the pandemic, no effects related to the coronavirus were discernible during the reporting period. Despite this upswing, a great deal of attention has been focused on the current geopolitical developments in connection with the conflict in Ukraine as well as the rise in inflation for over a year,” noted Warimpex CEO Franz Jurkowitsch.
Warimpex: weekly performance: 11.29%

RHI Magnesita: Ignite Luxembourg Holdings, which is indirectly managed by Private Equity Company Rhone, offered to buy a 20% stake in Austria headquartered refractory company RHI Magnesita at 2,850p per share in cash. In a brief statement, RHI management said: "The board is considering its response to the partial offer and a further announcement will be made in due course."
RHI Magnesita: weekly performance: 25.10%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (30/05/2023)

BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Plausch S5/44: Drei Börse Main Events namens Novomatic, EuroTeleSites und Bawag, hinten ein Spoiler



1. Valneva - Valneva Has a Specialist Travel Vaccine Business and is a Contractor to the US Military   >> Öffnen auf photaq.com

Aktien auf dem Radar:Telekom Austria, Strabag, S Immo, Austriacard Holdings AG, Pierer Mobility, Warimpex, FACC, Semperit, ams-Osram, Cleen Energy, Gurktaler AG Stamm, Verbund, BKS Bank Stamm, Zumtobel, Kapsch TrafficCom, Amag, CA Immo, EVN, Flughafen Wien, Immofinanz, Marinomed Biotech, OMV, Österreichische Post, Uniqa, VIG, Frequentis, SAP, Fresenius, DAIMLER TRUCK HLD..., Münchener Rück, Brenntag.

Random Partner

Erforscht und entwickelt völlig neuartige Technologieplattformen, die innovative Therapien gegen Atemwegs- und Augenerkrankungen ermöglichen. Aus wissenschaftlichen Ideen werden so neue Patente, Marken und Produkte geschaffen.

>> Besuchen Sie 66 weitere Partner auf boerse-social.com/partner